Ncats rare disease programs support
Ended Awarded Last action
- Contract number
- 75N95022F00150
- Awardee
-
The Mitre Corporation UEI DMHDNDCPWUD1 Part of The Mitre Corporation
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,435,475
Award facts
- Opportunity
-
- 75N95022R00103 Solicitation number
- Contract value 100% obligated
- $1,435,475.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- West McLean, VA 22102, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $319,502 | |
| Supplemental Agreement for work within scope | $124,745 | |
| Exercise an Option | $561,884 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $429,344 |
About this award
The National Institutes of Health National Center for Advancing Translational Sciences awarded a $1,435,475 delivery order contract to The Mitre Corporation to provide support for the Rare Disease Programs. The contract, which runs from September 29, 2022 through September 28, 2023, will be performed by The Mitre Corporation in McLean, Virginia. Pricing is set as cost plus fixed fee.
Quick answers
Who was awarded contract 75N95022F00150?
75N95022F00150 was awarded to The Mitre Corporation by National Institute on Drug Abuse (National Institutes of Health) on September 29, 2022.
How much is contract 75N95022F00150 worth?
The government has obligated $1,435,475 on 75N95022F00150.
Which agency awarded contract 75N95022F00150?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95022F00150, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Is contract 75N95022F00150 an order under another contract?
Yes. 75N95022F00150 is a delivery order under 75FCMC18D0047, an indefinite delivery contract.
Was contract 75N95022F00150 competed?
The extent of competition for 75N95022F00150 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award